Figure 6.
MMC treatment at 1, 1.5, or 2 mg/kg in combination with curcumin at 100 mg/kg downregulated the levels of cyclin D, cyclin E, cyclin A, CDK2, and CDK4 and upregulated p21 and p27 levels. The MCF-7 xenografts were treated with either curcumin at 100 mg/kg or MMC at 1, 1.5, and 2 mg/kg alone or in combination, and Western blot analysis was performed with antibodies specific to cyclin D1, cyclin E, cyclin A, CDK2, CDK4, p21, p27, and p-p38. The density ratio of proteins to GAPDH was shown as a relative expression. bP<0.05 vs 1.5 mg/kg MMC in combination with 100 mg/kg curcumin-treated group. eP<0.05 vs 2 mg/kg MMC in combination with 100 mg/kg curcumin-treated group. Values are mean±SD from 3 independent experiments.